Peripheral vascular embolization solution developer Instylla announced today that it appointed Sean Boyle as its new CEO.

Expanded applications within the cardiovascular system, peripheral vascular system, Ear, Nose, and Throat (ENT), and related fields are now within reach.

Background: Peripheral intravenous catheterization in children is challenging, and success rates vary greatly. We conducted a pragmatic randomized controlled trial to determine whether the use of ...

ABBOTT PARK, Ill., Sept. 2, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that it has acquired Walk Vascular, LLC, a commercial-stage medical device company with a minimally invasive ...

The FDA has designated a recall of a peripheral catheter system as class I, the most serious kind. Teleflex and its subsidiary Arrow International recalled the system (Arrow Endurance Extended ...

WAYNE, Pa - Intact Vascular, Inc., a private medical device company committed to developing solutions for minimally invasive peripheral vascular procedures, today announced it received U.S. Food and ...

Abbott (NYSE: ABT) announced today that it has acquired Walk Vascular, LLC, a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system designed to ...

While peripheral artery disease (PAD) is rare in pregnant women, there's a link between PAD and pregnancy complications. Find out about this connection.